143 related articles for article (PubMed ID: 11869711)
1. A 15-year retrospective study of hepatic resection for stage IV-A hepatocellular carcinoma shows value in hepatitis B negative patients.
Hanazaki K; Kajikawa S; Shimozawa N; Mihara M; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Am J Surg; 2002 Jan; 183(1):89-94. PubMed ID: 11869711
[TBL] [Abstract][Full Text] [Related]
2. HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case-control study.
Li Z; Zhao X; Jiang P; Xiao S; Wu G; Chen K; Zhang X; Liu H; Han X; Wang S; Li X
Medicine (Baltimore); 2016 Aug; 95(31):e4224. PubMed ID: 27495026
[TBL] [Abstract][Full Text] [Related]
3. Preoperative γ-glutamyl transpeptidase to platelet ratio (GPR) is an independent prognostic factor for HBV-related hepatocellular carcinoma after curative hepatic resection.
Wang WL; Zheng XL; Zhang ZY; Zhou Y; Hao J; Tang G; Li O; Xiang JX; Wu Z; Wang B
Medicine (Baltimore); 2016 Jul; 95(27):e4087. PubMed ID: 27399101
[TBL] [Abstract][Full Text] [Related]
4. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
[TBL] [Abstract][Full Text] [Related]
5. The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery.
Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
Dig Surg; 2018; 35(3):243-251. PubMed ID: 28810252
[TBL] [Abstract][Full Text] [Related]
6. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.
Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W
J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.
Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Takayama T; Kokudo N;
Ann Surg; 2015 Mar; 261(3):513-20. PubMed ID: 25072437
[TBL] [Abstract][Full Text] [Related]
8. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China.
Liao R; Fu YP; Wang T; Deng ZG; Li DW; Fan J; Zhou J; Feng GS; Qiu SJ; Du CY
Oncotarget; 2017 Jan; 8(1):1774-1787. PubMed ID: 27662665
[TBL] [Abstract][Full Text] [Related]
9. Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.
Yang SL; Liu LP; Sun YF; Yang XR; Fan J; Ren JW; Chen GG; Lai PB
J Gastroenterol; 2016 Jul; 51(7):722-32. PubMed ID: 26607653
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
[TBL] [Abstract][Full Text] [Related]
11. Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.
Zhang ZY; Zhou ZQ; Zhou GW
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1116-24. PubMed ID: 25003747
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels.
Huang G; Lau WY; Zhou WP; Shen F; Pan ZY; Yuan SX; Wu MC
JAMA Surg; 2014 Jun; 149(6):519-27. PubMed ID: 24696192
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognosis of non-B, non-C hepatocellular carcinoma: The impact of patient sex on disease-free survival - A retrospective cohort study.
Hashimoto M; Tashiro H; Kobayashi T; Kuroda S; Hamaoka M; Ohdan H
Int J Surg; 2017 Mar; 39():206-213. PubMed ID: 28159713
[TBL] [Abstract][Full Text] [Related]
14. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma.
Sasaki Y; Yamada T; Tanaka H; Ohigashi H; Eguchi H; Yano M; Ishikawa O; Imaoka S
Ann Surg; 2006 Nov; 244(5):771-80. PubMed ID: 17060771
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of long-term survival and recurrence after curative resection of hepatocellular carcinoma.
Hanazaki K; Matsushita A; Nakagawa K; Misawa R; Amano J
Hepatogastroenterology; 2005; 52(62):552-7. PubMed ID: 15816476
[TBL] [Abstract][Full Text] [Related]
16. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection.
Zhu WJ; Huang CY; Li C; Peng W; Wen TF; Yan LN; Li B; Wang WT; Xu MQ; Yang JY; Jiang L
Asian Pac J Cancer Prev; 2013; 14(12):7101-6. PubMed ID: 24460258
[TBL] [Abstract][Full Text] [Related]
18. Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection.
Chen JL; Lin XJ; Zhou Q; Shi M; Li SP; Lao XM
Chin J Cancer; 2016 Mar; 35():28. PubMed ID: 26992891
[TBL] [Abstract][Full Text] [Related]
19. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
Li T; Qin LX; Gong X; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
Cancer; 2013 Jan; 119(1):126-35. PubMed ID: 22736338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]